Systemic Treatment of Ocular Inflammatory Disease (OID)

Systemic Treatment of Ocular Inflammatory Disease (OID) C. Stephen Foster, M.D. Most eye diseases which are treatable are treated with eye drops. In fact, the number of instances in which patients attending a general ophthalmologist’s office might be prescribed a systemic medication (i.e., one whi...

Continue reading →

Chemotherapy: Risks and Outcomes

Chemotherapy: Risks and Outcomes C. Stephen Foster, M.D. Inflammatory eye disease has blinded countless numbers of individuals during both ancient and modern times. And while most of such instances have occurred on the basis of infectious inflammation, not a trivial number of instances has occurred ...

Continue reading →

Cost of Care of Patients with Uveitis

Cost of Care of Patients with Uveitis C. Stephen Foster, M.D. Increasingly restrictive “gate keeping” policies of health maintenance organizations, insurance companies, and other medical insurance plans have created increasing pressure on ophthalmologists to be parsimonious in their use of med...

Continue reading →


Cataract C. Stephen Foster, M.D. CATARACT: a scum or a film or a growth on the eye: right? Wrong! A cataract is none of these. The word cataract simply means the development of an opacity in the crystalline lens inside the eye. We all have such a lens sitting just behind the pupil. And this lens doe...

Continue reading →


Glaucoma C. Stephen Foster, M.D. What is it? Some misconceptions exist regarding glaucoma. One thing that most of the public does understand, however, is that glaucoma is serious and is potentially blinding. Many people, however, harbor the misconception that glaucoma produces pain. Indeed, there is...

Continue reading →

April is Sarcoidosis Awareness Month

Of the many causes of ocular inflammation, one of the more frequently seen causes, and frankly one many patients have never before heard of, is ocular sarcoidosis, or simply “sarcoid”. Sarcoid is a systemic autoinflammatory disease that can affect multiple parts of the body and cause var...

Continue reading →

Age-Related Macular Degeneration

Epidemiology Age-related macular degeneration (AMD) is the number 1 cause of blindness in the Western world. It affects 8 million Americans, including more than 30% of American older than 75 years of age. Even though it is a disease that mostly affects the older population, as many as 6-7% of popula...

Continue reading →

Uveitic Glaucoma

Uveitis is the third leading cause of preventable blindness in this country, but many people who suffer from this group of diseases lose their vision via other another mechanism – glaucoma. Glaucoma is the ‘sneak thief’ of vision, a blinding disease of the optic nerve, or the structure that co...

Continue reading →

Diabetic Retinopathy

Diabetes affects 415 million adults worldwide, and it is becoming more prevalent in children and adolescent thanks to the unhealthy diets and physical inactivity that have become the hallmarks of our modern society. Excessive hunger and thirst, frequent urination, weight loss, fatigue, and blurry vi...

Continue reading →

An Introduction to Ocular Autoimmune Disease

The immune system, ordinarily in the “business” of protecting us from harm, generally protecting us from germs and cancer cells, can become deranged, with the result being an immune attack on part of our own body. This state of affairs is termed autoimmunity, or immune attack against sel...

Continue reading →

Pediatric Uveitis

Uveitis is the third leading cause of blindness in America, and 5% to 10% of the cases occur in children under the age of 16. But uveitis in children blinds a larger percentage of those affected than in adults, since 40% of the cases occurring in children are posterior uveitis, compared to the 20% o...

Continue reading →

  • Our Physicians

    All of our physicians have completed Fellowships in their specialty.

    Make an Appointment
  • How was your experience?

  • Join our mailing list

  • Specialty Services

    From the treatment of common eye conditions to the ongoing management of complex systemic eye diseases, MERSI is committed to meeting the needs of each individual patient.

    View all